Abstract

Microbial glycan microarrays (MGMs) populated with purified microbial glycans have been used to define the specificity of host immune factors toward microbes in a high throughput manner. However, a limitation of such arrays is that glycan presentation may not fully recapitulate the natural presentation that exists on microbes. This raises the possibility that interactions observed on the array, while often helpful in predicting actual interactions with intact microbes, may not always accurately ascertain the overall affinity of a host immune factor for a given microbe. Using galectin-8 (Gal-8) as a probe, we compared the specificity and overall affinity observed using a MGM populated with glycans harvested from various strains of Streptococcus pneumoniae to an intact microbe microarray (MMA). Our results demonstrate that while similarities in binding specificity between the MGM and MMA are apparent, Gal-8 binding toward the MMA more accurately predicted interactions with strains of S. pneumoniae, including the overall specificity of Gal-8 antimicrobial activity. Taken together, these results not only demonstrate that Gal-8 possesses antimicrobial activity against distinct strains of S. pneumoniae that utilize molecular mimicry, but that microarray platforms populated with intact microbes present an advantageous strategy when exploring host interactions with microbes.

Details

Title
Whole microbe arrays accurately predict interactions and overall antimicrobial activity of galectin-8 toward distinct strains of Streptococcus pneumoniae
Author
Wu, Shang-Chuen 1 ; Jan, Hau-Ming 1 ; Vallecillo-Zúniga, Mary L. 1 ; Rathgeber, Matthew F. 1 ; Stowell, Caleb S. 1 ; Murdock, Kaleb L. 1 ; Patel, Kashyap R. 1 ; Nakahara, Hirotomo 1 ; Stowell, Carter J. 1 ; Nahm, Moon H. 2 ; Arthur, Connie M. 1 ; Cummings, Richard D. 3   VIAFID ORCID Logo  ; Stowell, Sean R. 1 

 Harvard Medical School, Joint Program in Transfusion Medicine, Department of Pathology, Brigham and Women’s Hospital, National Center for Functional Glycomics, 630E New Research Building, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 University of Alabama at Birmingham, Department of Medicine, Alabama, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 Harvard Medical School, Harvard Glycomics Center, Beth Israel Deaconess Medical Center, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
Pages
5324
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2793847109
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.